 |
JAKARTA, Indonesia, March 5, 2019 /PRNewswire/ — Halodoc, Indonesia’s leading healthcare platform, has raised US$65 million in Series B funding, led by new investor UOB Venture Management. Other new investors in the financing round include Singtel Innov8, Korea Investment Partners and WuXi AppTec. Existing investors also participated.
Halodoc Pharmacy Delivery
Halodoc is a digital healthcare platform that includes a mobile app and website allowing customers across Indonesia to have live consultations with more than 20,000 licensed doctors in the country, anytime, anywhere. Its platform usage grew by 2500% in 2018, demonstrating robust demand for healthcare convenience. Customers can order lab tests to be carried out in their home and use the app to order medication from 1,300 participating pharmacies, which can be delivered within an hour.
Halodoc has teamed with more than 1,400 hospitals and healthcare providers in a nationwide partnership to improve the hospital visit experience. The partnership provides customers with shortened wait times at the pharmacy post appointment and a cashless hospital visit through linking of insurance benefits. Halodoc will use the new funds to perfect the online to offline healthcare experience with hospitals and insurance partners as its roll-out continues in 2019.
Halodoc was named “Most Innovative Start-up in Asia in November 2018“ by Galen Growth Asia, an organisation that monitors the healthcare start-up ecosystem in Asia Pacific.
Jonathan Sudharta, Founder and Chief Executive Officer, Halodoc, said, “Today, we provide two million customers with convenient and reliable healthcare services monthly, of which half reside outside Java. There is a huge potential for technology to extend the reach of conventional healthcare, providing better access for the archipelago’s large population. The strategic investments and partnerships will enable us to accelerate our efforts in building a platform that improves access and convenience to millions of Indonesian customers.”
Kian-Wee Seah, Managing Director and CEO, UOB Venture Management, said, “Halodoc’s vision is to use technology to make quality healthcare more accessible for everyone and to optimize finite healthcare resources in a vast country such as Indonesia. This investment in Halodoc is a reflection of our responsible investing approach to support economic and social development.”
Halodoc has worked closely with its existing investors, Openspace Ventures, Clermont Group, Blibli.com and InvestIdea who share a similar vision for the future of healthcare. Whilst Halodoc’s strategic partner GOJEK Group, continues its commitment to Halodoc’s success. Andre Soelistyo, President GOJEK said, “At GOJEK, we focus relentlessly on solving problems and making life better for people throughout Indonesia and Southeast Asia. Halodoc very much shares this ethos, which is why the company was one of our earliest ecosystem partners. We worked together to create GO-MED, through which Halodoc’s services are made available to millions of our users through the GOJEK app. We are proud to support the company and its management team and look forward to deepening the integration between our two platforms.”
Photo – https://photos.prnasia.com/prnh/20190305/2393476-1
Logo – https://photos.prnasia.com/prnh/20190305/2393476-1LOGO
Facebook Comments